{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:31:36Z","timestamp":1791923496273,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870403"],"award-info":[{"award-number":["81870403"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401122"],"award-info":[{"award-number":["81401122"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Scientific Research Platform for Collaborative Tackling of Universities and Collaborative Innovation of Public Health in Anhui Province","award":["GXXT-2020-062"],"award-info":[{"award-number":["GXXT-2020-062"]}]},{"name":"Anhui Provincial Quality Engineering Project of Higher Education Institutions","award":["2020jyxm0868"],"award-info":[{"award-number":["2020jyxm0868"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Quercetin (QUE) is a flavonol reported with anti-inflammatory and antioxidant activities, and previous results from the group of this study have demonstrated its neuroprotective effect against lipopolysaccharide-induced neuropsychiatric injuries. However, little is known about its potential effect on neuropsychiatric injuries induced or accompanied by metabolic dysfunction of glucose and lipids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A nonalcoholic fatty liver disease (NAFLD) rat model was induced via a high-fat diet (HFD), and glucolipid parameters and liver function were measured. Behavioral performance was observed via the open field test (OFT) and the Morris water maze (MWM). The plasma levels of triggering receptor expressed on myeloid cells-1 (TREM1) and TREM2 were measured via enzyme-linked immunosorbent assay (ELISA). The protein expression levels of Synapsin-1 (Syn-1), Synaptatogmin-1 (Syt-1), TREM1 and TREM2 in the hippocampus were detected using western blotting. Morphological changes in the liver and hippocampus were detected by HE and Oil red or silver staining.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with the control rats, HFD-induced NAFLD model rats presented significant metabolic dysfunction, hepatocyte steatosis, and impaired learning and memory ability, as indicated by the increased plasma concentrations of total cholesterol (TC) and triglyceride (TG), the impaired glucose tolerance, the accumulated fat droplets and balloon-like changes in the liver, and the increased escaping latency but decreased duration in the target quadrant in the Morris water maze. All these changes were reversed in QUE-treated rats. Moreover, apart from improving the morphological injuries in the hippocampus, treatment with QUE could increase the decreased plasma concentration and hippocampal protein expression of TREM1 in NAFLD rats and increase the decreased expression of Syn-1 and Syt-1 in the hippocampus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results suggested the therapeutic potential of QUE against NAFLD-associated impairment of learning and memory, and the mechanism might involve regulating the metabolic dysfunction of glucose and lipids and balancing the protein expression of synaptic plasticity markers and TREM1\/2 in the hippocampus.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12944-021-01590-x","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T05:04:28Z","timestamp":1637125468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Protective effect of quercetin against the metabolic dysfunction of glucose and lipids and its associated learning and memory impairments in NAFLD rats"],"prefix":"10.1186","volume":"20","author":[{"given":"Xin-Ran","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Xian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Fang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"1590_CR1","doi-asserted-by":"publisher","first-page":"e2630","DOI":"10.1097\/MD.0000000000002630","volume":"95","author":"R Jamali","year":"2016","unstructured":"Jamali R, Arj A, Razavizade M, Aarabi MH. Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines. Medicine (Baltimore). 2016;95:e2630. https:\/\/doi.org\/10.1097\/MD.0000000000002630.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"1590_CR2","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1097\/MEG.0000000000001131","volume":"30","author":"A Celikbilek","year":"2018","unstructured":"Celikbilek A, Celikbilek M, Bozkurt G. Cognitive assessment of patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2018;30(8):944\u201350. https:\/\/doi.org\/10.1097\/MEG.0000000000001131.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"1590_CR3","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/apt.15395","volume":"50","author":"D Kim","year":"2019","unstructured":"Kim D, Yoo ER, Li AA, Tighe SP, Cholankeril G, Harrison SA, et al. Depression is associated with non-alcoholic fatty liver disease among adults in the United States. Aliment Pharmacol Ther. 2019;50(5):590\u20138. https:\/\/doi.org\/10.1111\/apt.15395.","journal-title":"Aliment Pharmacol Ther"},{"key":"1590_CR4","doi-asserted-by":"publisher","first-page":"9638797","DOI":"10.1155\/2018\/9638797","volume":"2018","author":"B Filipovic","year":"2018","unstructured":"Filipovic B, Markovic O, Duric V, Filipovic B. Cognitive changes and brain volume reduction in patients with nonalcoholic fatty liver disease. Can J Gastroenterol Hepatol. 2018;2018:9638797\u20136. https:\/\/doi.org\/10.1155\/2018\/9638797.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"4","key":"1590_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11011-011-9261-y","volume":"26","author":"DA Ghareeb","year":"2011","unstructured":"Ghareeb DA, Hafez HS, Hussien HM, Kabapy NF. Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction. Metab Brain Dis. 2011;26(4):253\u201367. https:\/\/doi.org\/10.1007\/s11011-011-9261-y.","journal-title":"Metab Brain Dis"},{"key":"1590_CR6","doi-asserted-by":"publisher","unstructured":"Chen Z, Xu YY, Wu R, Han YX, Yu Y, Ge JF, et al. Impaired learning and memory in rats induced by a high-fat diet: Involvement with the imbalance of nesfatin-1 abundance and copine 6 expression. J Neuroendocrinol. 2017;29. https:\/\/doi.org\/10.1111\/jne.12462.","DOI":"10.1111\/jne.12462"},{"issue":"9","key":"1590_CR7","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1111\/liv.14161","volume":"39","author":"G Weinstein","year":"2019","unstructured":"Weinstein G, Davis-Plourde K, Himali JJ, Zelber-Sagi S, Beiser AS, Seshadri S. Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: the Framingham study. Liver Int. 2019;39(9):1713\u201321. https:\/\/doi.org\/10.1111\/liv.14161.","journal-title":"Liver Int"},{"issue":"3","key":"1590_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.cmet.2007.08.006","volume":"6","author":"M Matsumoto","year":"2007","unstructured":"Matsumoto M, Pocai A, Rossetti L, Depinho RA, Accili D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab. 2007;6(3):208\u201316. https:\/\/doi.org\/10.1016\/j.cmet.2007.08.006.","journal-title":"Cell Metab"},{"key":"1590_CR9","doi-asserted-by":"publisher","first-page":"104501","DOI":"10.1016\/j.neuint.2019.104501","volume":"129","author":"T Ren","year":"2019","unstructured":"Ren T, Liu J, Ge Y, Zhuo R, Peng L, Liu F, et al. Chronic oleoylethanolamide treatment attenuates diabetes-induced mice encephalopathy by triggering peroxisome proliferator-activated receptor alpha in the hippocampus. Neurochem Int. 2019;129:104501. https:\/\/doi.org\/10.1016\/j.neuint.2019.104501.","journal-title":"Neurochem Int"},{"issue":"3","key":"1590_CR10","doi-asserted-by":"publisher","first-page":"e01412","DOI":"10.1016\/j.heliyon.2019.e01412","volume":"5","author":"AR Lewis","year":"2019","unstructured":"Lewis AR, Singh S, Youssef FF. Cafeteria-diet induced obesity results in impaired cognitive functioning in a rodent model. Heliyon. 2019;5(3):e01412. https:\/\/doi.org\/10.1016\/j.heliyon.2019.e01412.","journal-title":"Heliyon."},{"issue":"1016","key":"1590_CR11","doi-asserted-by":"publisher","first-page":"107668","DOI":"10.1016\/j.neuropharm.2019.107668","volume":"15710","author":"S Chen","year":"2019","unstructured":"Chen S, Zhou M, Sun J, Guo A, Fernando RL, Chen Y, et al. DPP-4 inhibitor improves learning and memory deficits and AD-like neurodegeneration by modulating the GLP-1 signaling. Neuropharmacology. 2019;15710(1016):107668. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107668.","journal-title":"Neuropharmacology"},{"issue":"4","key":"1590_CR12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/dom.12432","volume":"17","author":"VA Gault","year":"2015","unstructured":"Gault VA, Lennox R, Flatt PR. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline. Diabetes Obes Metab. 2015;17(4):403\u201313. https:\/\/doi.org\/10.1111\/dom.12432.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"1590_CR13","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1152\/jn.00092.2019","volume":"122","author":"J Karbowski","year":"2019","unstructured":"Karbowski J. Metabolic constraints on synaptic learning and memory. J Neurophysiol. 2019;122(4):1473\u201390. https:\/\/doi.org\/10.1152\/jn.00092.2019.","journal-title":"J Neurophysiol"},{"issue":"3","key":"1590_CR14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2174\/1871527316666170113120853","volume":"16","author":"SD Skaper","year":"2017","unstructured":"Skaper SD, Facci L, Zusso M, Giusti P. Synaptic plasticity, dementia and Alzheimer disease. CNS Neurol Disord Drug Targets. 2017;16(3):220\u201333. https:\/\/doi.org\/10.2174\/1871527316666170113120853.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"12","key":"1590_CR15","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1096\/fj.201600816R","volume":"30","author":"EJ Goetzl","year":"2016","unstructured":"Goetzl EJ, Kapogiannis D, Schwartz JB, Lobach IV, Goetzl L, Abner EL, et al. Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease. FASEB J. 2016;30(12):4141\u20138. https:\/\/doi.org\/10.1096\/fj.201600816R.","journal-title":"FASEB J"},{"issue":"5096","key":"1590_CR16","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1126\/science.8430330","volume":"259","author":"P Greengard","year":"1993","unstructured":"Greengard P, Valtorta F, Czernik AJ, Benfenati F. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science. 1993;259(5096):780\u20135. https:\/\/doi.org\/10.1126\/science.8430330.","journal-title":"Science"},{"issue":"4679","key":"1590_CR17","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1126\/science.6438799","volume":"226","author":"F Navone","year":"1984","unstructured":"Navone F, Greengard P, De Camilli P. Synapsin I in nerve terminals: selective association with small synaptic vesicles. Science. 1984;226(4679):1209\u201311. https:\/\/doi.org\/10.1126\/science.6438799.","journal-title":"Science"},{"key":"1590_CR18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3389\/fnins.2018.00731","volume":"12","author":"YX Han","year":"2018","unstructured":"Han YX, Tao C, Gao XR, Wang LL, Jiang FH, Wang C, et al. BDNF-related imbalance of Copine 6 and synaptic plasticity markers couples with depression-like behavior and immune activation in CUMS rats. Front Neurosci. 2018;12:731. https:\/\/doi.org\/10.3389\/fnins.2018.00731.","journal-title":"Front Neurosci"},{"key":"1590_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbr.2013.04.020","volume":"249","author":"JF Ge","year":"2013","unstructured":"Ge JF, Qi CC, Zhou JN. Imbalance of leptin pathway and hypothalamus synaptic plasticity markers are associated with stress-induced depression in rats. Behav Brain Res. 2013;249:38\u201343. https:\/\/doi.org\/10.1016\/j.bbr.2013.04.020.","journal-title":"Behav Brain Res"},{"issue":"3","key":"1590_CR20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s12020-013-0001-4","volume":"45","author":"JF Ge","year":"2014","unstructured":"Ge JF, Peng YY, Qi CC, Chen FH, Zhou JN. Depression-like behavior in subclinical hypothyroidism rat induced by hemi-thyroid electrocauterization. Endocrine. 2014;45(3):430\u20138. https:\/\/doi.org\/10.1007\/s12020-013-0001-4.","journal-title":"Endocrine"},{"key":"1590_CR21","doi-asserted-by":"publisher","first-page":"100243","DOI":"10.1016\/j.ynstr.2020.100243","volume":"13","author":"LT Yi","year":"2020","unstructured":"Yi LT, Zhu JX, Dong SQ, Li CF, Zhang QP, Cheng J, et al. miR-34a induces spine damages via inhibiting synaptotagmin-1 in depression. Neurobiol. Stress. 2020;13:100243. https:\/\/doi.org\/10.1016\/j.ynstr.2020.100243.","journal-title":"Stress"},{"issue":"5","key":"1590_CR22","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1007\/s12035-015-9182-6","volume":"53","author":"AE Freitas","year":"2016","unstructured":"Freitas AE, Egea J, Buendia I, Gomez-Rangel V, Parada E, Navarro E, et al. Agmatine, by improving neuroplasticity markers and inducing Nrf2, prevents corticosterone-induced depressive-like behavior in mice. Mol Neurobiol. 2016;53(5):3030\u201345. https:\/\/doi.org\/10.1007\/s12035-015-9182-6.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1590_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.coi.2009.01.009","volume":"21","author":"JW Ford","year":"2009","unstructured":"Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol. 2009;21(1):38\u201346. https:\/\/doi.org\/10.1016\/j.coi.2009.01.009.","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"1590_CR24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00401-016-1622-5","volume":"132","author":"T Jiang","year":"2016","unstructured":"Jiang T, Zhang YD, Gao Q, Zhou JS, Zhu XC, Lu H, et al. TREM1 facilitates microglial phagocytosis of amyloid beta. Acta Neuropathol. 2016;132(5):667\u201383. https:\/\/doi.org\/10.1007\/s00401-016-1622-5.","journal-title":"Acta Neuropathol"},{"issue":"40","key":"1590_CR25","doi-asserted-by":"publisher","first-page":"10172","DOI":"10.1073\/pnas.1811411115","volume":"115","author":"FA Sayed","year":"2018","unstructured":"Sayed FA, Telpoukhovskaia M, Kodama L, Li Y, Zhou Y, Le D, et al. Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy. Proc Natl Acad Sci U S A. 2018;115(40):10172\u20137. https:\/\/doi.org\/10.1073\/pnas.1811411115.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1590_CR26","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s12035-016-9704-x","volume":"54","author":"T Jiang","year":"2017","unstructured":"Jiang T, Wan Y, Zhang YD, Zhou JS, Gao Q, Zhu XC, et al. TREM2 overexpression has no improvement on neuropathology and cognitive impairment in aging APPswe\/PS1dE9 mice. Mol Neurobiol. 2017;54(2):855\u201365. https:\/\/doi.org\/10.1007\/s12035-016-9704-x.","journal-title":"Mol Neurobiol"},{"key":"1590_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fncel.2018.00206","volume":"12","author":"H Konishi","year":"2018","unstructured":"Konishi H, Kiyama H. Microglial TREM2\/DAP12 signaling: a double-edged sword in neural diseases. Front Cell Neurosci. 2018;12:206. https:\/\/doi.org\/10.3389\/fncel.2018.00206.","journal-title":"Front Cell Neurosci"},{"key":"1590_CR28","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3389\/fphar.2019.01544","volume":"10","author":"K Fang","year":"2019","unstructured":"Fang K, Li HR, Chen XX, Gao XR, Huang LL, Du AQ, et al. Quercetin alleviates LPS-induced depression-like behavior in rats via regulating BDNF-related imbalance of Copine 6 and TREM1\/2 in the Hippocampus and PFC. Front Pharmacol. 2019;10:1544. https:\/\/doi.org\/10.3389\/fphar.2019.01544.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1590_CR29","first-page":"284","volume":"8","author":"ZF Dou","year":"2016","unstructured":"Dou ZF, Guo YR, Liu JC, Li N, Chai B, Li XQ, et al. Ameliorative effects of glycine in an experimental nonalcoholic steatohepatitis and its correlation between TREM-1 and TREM-2. Am J Transl Res. 2016;8(2):284\u201397.","journal-title":"Am J Transl Res"},{"issue":"1","key":"1590_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/fsn3.1291","volume":"8","author":"L Peng","year":"2020","unstructured":"Peng L, Zhang Q, Zhang Y, Yao Z, Song P, Wei L, et al. Effect of tartary buckwheat, rutin, and quercetin on lipid metabolism in rats during high dietary fat intake. Food Sci Nutr. 2020;8(1):199\u2013213. https:\/\/doi.org\/10.1002\/fsn3.1291.","journal-title":"Food Sci Nutr"},{"key":"1590_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.physbeh.2017.01.006","volume":"171","author":"V Mehta","year":"2017","unstructured":"Mehta V, Parashar A, Udayabanu M. Quercetin prevents chronic unpredictable stress induced behavioral dysfunction in mice by alleviating hippocampal oxidative and inflammatory stress. Physiol Behav. 2017;171:69\u201378. https:\/\/doi.org\/10.1016\/j.physbeh.2017.01.006.","journal-title":"Physiol Behav"},{"issue":"2","key":"1590_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40265-016-0686-9","volume":"77","author":"LJ Scott","year":"2017","unstructured":"Scott LJ. Sitagliptin: a review in type 2 diabetes. Drugs. 2017;77(2):209\u201324. https:\/\/doi.org\/10.1007\/s40265-016-0686-9.","journal-title":"Drugs"},{"issue":"6","key":"1590_CR33","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1002\/hep.30320","volume":"69","author":"J Yan","year":"2019","unstructured":"Yan J, Yao B, Kuang H, Yang X, Huang Q, Hong T, et al. Liraglutide, Sitagliptin, and insulin glargine added to metformin: the effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease. Hepatology. 2019;69(6):2414\u201326. https:\/\/doi.org\/10.1002\/hep.30320.","journal-title":"Hepatology"},{"key":"1590_CR34","doi-asserted-by":"publisher","first-page":"108119","DOI":"10.1016\/j.diabres.2020.108119","volume":"162","author":"K Tanimura-Inagaki","year":"2020","unstructured":"Tanimura-Inagaki K, Nagao M, Harada T, Sugihara H, Moritani S, Sasaki J, et al. Sitagliptin improves plasma apolipoprotein profile in type 2 diabetes: a randomized clinical trial of sitagliptin effect on lipid and glucose metabolism (SLIM) study. Diabetes Res Clin Pract. 2020;162:108119. https:\/\/doi.org\/10.1016\/j.diabres.2020.108119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"1590_CR35","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/dom.13373","volume":"20","author":"B Cao","year":"2018","unstructured":"Cao B, Rosenblat JD, Brietzke E, Park C, Lee Y, Musial N, et al. Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: a systematic review and network meta-analysis. Diabetes Obes Metab. 2018;20(10):2467\u201371. https:\/\/doi.org\/10.1111\/dom.13373.","journal-title":"Diabetes Obes Metab"},{"key":"1590_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.fct.2018.02.019","volume":"114","author":"X Zhu","year":"2018","unstructured":"Zhu X, Xiong T, Liu P, Guo X, Xiao L, Zhou F, et al. Quercetin ameliorates HFD-induced NAFLD by promoting hepatic VLDL assembly and lipophagy via the IRE1a\/XBP1s pathway. Food Chem Toxicol. 2018;114:52\u201360. https:\/\/doi.org\/10.1016\/j.fct.2018.02.019.","journal-title":"Food Chem Toxicol"},{"key":"1590_CR37","doi-asserted-by":"publisher","first-page":"105618","DOI":"10.1016\/j.biocel.2019.105618","volume":"117","author":"F Damiano","year":"2019","unstructured":"Damiano F, Giannotti L, Gnoni GV, Siculella L, Gnoni A. Quercetin inhibition of SREBPs and ChREBP expression results in reduced cholesterol and fatty acid synthesis in C6 glioma cells. Int J Biochem Cell Biol. 2019;117:105618. https:\/\/doi.org\/10.1016\/j.biocel.2019.105618.","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"1590_CR38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.bbalip.2016.02.003","volume":"2016","author":"L Siculella","year":"1861","unstructured":"Siculella L, Tocci R, Rochira A, Testini M, Gnoni A, Damiano F. Lipid accumulation stimulates the cap-independent translation of SREBP-1a mRNA by promoting hnRNP A1 binding to its 5'-UTR in a cellular model of hepatic steatosis. Biochim Biophys Acta. 1861;2016(5):471\u201381. https:\/\/doi.org\/10.1016\/j.bbalip.2016.02.003.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"1590_CR39","doi-asserted-by":"publisher","first-page":"e12473","DOI":"10.1111\/jne.12473","volume":"29","author":"T Jois","year":"2017","unstructured":"Jois T, Sleeman MW. The regulation and role of carbohydrate response element-binding protein in metabolic homeostasis and disease. J Neuroendocrinol. 2017;29(10):e12473. https:\/\/doi.org\/10.1111\/jne.12473.","journal-title":"J Neuroendocrinol"},{"issue":"11","key":"1590_CR40","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1007\/s11064-021-03398-8","volume":"46","author":"JX Xu","year":"2021","unstructured":"Xu JX, Fang K, Gao XR, Liu S, Ge JF. Resveratrol protects SH-SY5Y cells against oleic acid-induced glucolipid metabolic dysfunction and cell injuries via the Wnt\/beta-catenin Signalling pathway. Neurochem Res. 2021;46(11):2936\u201347. https:\/\/doi.org\/10.1007\/s11064-021-03398-8.","journal-title":"Neurochem Res"},{"key":"1590_CR41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fnagi.2019.00174","volume":"11","author":"LD Estrada","year":"2019","unstructured":"Estrada LD, Ahumada P, Cabrera D, Arab JP. Liver dysfunction as a novel player in Alzheimer's progression: looking outside the brain. Front Aging Neurosci. 2019;11:174. https:\/\/doi.org\/10.3389\/fnagi.2019.00174.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"1590_CR42","doi-asserted-by":"publisher","first-page":"e13125","DOI":"10.1111\/acel.13125,","volume":"19","author":"Z Shi","year":"2020","unstructured":"Shi Z, Zhang K, Zhou H, Jiang L, Xie B, Wang R, et al. Increased miR-34c mediates synaptic deficits by targeting synaptotagmin 1 through ROS-JNK-p53 pathway in Alzheimer's disease. Aging Cell. 2020;19(3):e13125. https:\/\/doi.org\/10.1111\/acel.13125,.","journal-title":"Aging Cell"},{"issue":"6","key":"1590_CR43","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s10571-014-0068-3","volume":"34","author":"FX Zhang","year":"2014","unstructured":"Zhang FX, Sun QJ, Zheng XY, Lin YT, Shang W, Wang AH, et al. Abnormal expression of synaptophysin, SNAP-25, and synaptotagmin 1 in the hippocampus of kainic acid-exposed rats with behavioral deficits. Cell Mol Neurobiol. 2014;34(6):813\u201324. https:\/\/doi.org\/10.1007\/s10571-014-0068-3.","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"1590_CR44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000496845","volume":"109","author":"O Fernandez-Gayol","year":"2019","unstructured":"Fernandez-Gayol O, Sanchis P, Aguilar K, Navarro-Sempere A, Comes G, Molinero A, et al. Different responses to a high-fat diet in IL-6 conditional knockout mice driven by constitutive GFAP-Cre and Synapsin 1-Cre expression. Neuroendocrinology. 2019;109(2):113\u201330. https:\/\/doi.org\/10.1159\/000496845.","journal-title":"Neuroendocrinology"},{"issue":"3","key":"1590_CR45","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s12264-018-0324-5","volume":"35","author":"AH Liu","year":"2019","unstructured":"Liu AH, Chu M, Wang YP. Up-regulation of Trem2 inhibits hippocampal neuronal apoptosis and alleviates oxidative stress in epilepsy via the PI3K\/Akt pathway in mice. Neurosci Bull. 2019;35(3):471\u201385. https:\/\/doi.org\/10.1007\/s12264-018-0324-5.","journal-title":"Neurosci Bull"},{"issue":"13","key":"1590_CR46","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1038\/npp.2014.164","volume":"39","author":"T Jiang","year":"2014","unstructured":"Jiang T, Tan L, Zhu XC, Zhang QQ, Cao L, Tan MS, et al. Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease. Neuropsychopharmacology. 2014;39(13):2949\u201362. https:\/\/doi.org\/10.1038\/npp.2014.164.","journal-title":"Neuropsychopharmacology"},{"key":"1590_CR47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","volume":"22","author":"S Parhizkar","year":"2019","unstructured":"Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci. 2019;22:191\u2013204. https:\/\/doi.org\/10.1038\/s41593-018-0296-9.","journal-title":"Nat Neurosci"},{"issue":"12","key":"1590_CR48","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1016\/j.neurobiolaging.2015.08.019","volume":"36","author":"T Jiang","year":"2015","unstructured":"Jiang T, Tan L, Zhu XC, Zhou JS, Cao L, Tan MS, et al. Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice. Neurobiol Aging. 2015;36(12):3176\u201386. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.08.019.","journal-title":"Neurobiol Aging"},{"key":"1590_CR49","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3389\/fendo.2019.00434","volume":"10","author":"XX Chen","year":"2019","unstructured":"Chen XX, Xu YY, Wu R, Chen Z, Fang K, Han YX, et al. Resveratrol Reduces Glucolipid Metabolic Dysfunction and Learning and Memory Impairment in a NAFLD Rat Model: Involvement in Regulating the Imbalance of Nesfatin-1 Abundance and Copine 6 Expression. Front Endocrinol (Lausanne). 2019;10:434. https:\/\/doi.org\/10.3389\/fendo.2019.00434.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1590_CR50","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1039\/d0fo01900c","volume":"12","author":"H Li","year":"2021","unstructured":"Li H, Chen FJ, Yang WL, Qiao HZ, Zhang SJ. Quercetin improves cognitive disorder in aging mice by inhibiting NLRP3 inflammasome activation. Food Funct. 2021;12(2):717\u201325. https:\/\/doi.org\/10.1039\/d0fo01900c.","journal-title":"Food Funct"},{"issue":"1","key":"1590_CR51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijdevneu.2019.02.005","volume":"74","author":"M Karimipour","year":"2019","unstructured":"Karimipour M, Rahbarghazi R, Tayefi H, Shimia M, Ghanadian M, Mahmoudi J, et al. Quercetin promotes learning and memory performance concomitantly with neural stem\/progenitor cell proliferation and neurogenesis in the adult rat dentate gyrus. Int J Dev Neurosci. 2019;74(1):18\u201326. https:\/\/doi.org\/10.1016\/j.ijdevneu.2019.02.005.","journal-title":"Int J Dev Neurosci"},{"issue":"1","key":"1590_CR52","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.sjbs.2020.10.030","volume":"28","author":"NK Kalagatur","year":"2021","unstructured":"Kalagatur NK, Abd AE, Poda S, Kadirvelu K, Hashem A, Mudili V, et al. Quercetin mitigates the deoxynivalenol mycotoxin induced apoptosis in SH-SY5Y cells by modulating the oxidative stress mediators. Saudi J Biol Sci. 2021;28(1):465\u201377. https:\/\/doi.org\/10.1016\/j.sjbs.2020.10.030.","journal-title":"Saudi J Biol Sci"},{"issue":"1","key":"1590_CR53","doi-asserted-by":"publisher","first-page":"e000392","DOI":"10.1136\/bmjresp-2018-000392","volume":"7","author":"MK Han","year":"2020","unstructured":"Han MK, Barreto TA, Martinez FJ, Comstock AT, Sajjan US. Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease. BMJ Open Respir Res. 2020;7(1):e000392. https:\/\/doi.org\/10.1136\/bmjresp-2018-000392.","journal-title":"BMJ Open Respir Res"},{"key":"1590_CR54","doi-asserted-by":"publisher","unstructured":"Smoak P, Burke SJ, Collier JJ. Botanical interventions to improve glucose control and options for diabetes therapy [published online ahead of print, August 15, 2021]. SN Compr Clin Med. 2021. https:\/\/doi.org\/10.1007\/s42399-021-01034-8.","DOI":"10.1007\/s42399-021-01034-8"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01590-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-021-01590-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01590-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T05:10:20Z","timestamp":1637125820000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-021-01590-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1590"],"URL":"https:\/\/doi.org\/10.1186\/s12944-021-01590-x","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"assertion":[{"value":"15 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal care practices and experimental procedures were approved by the Animal Care and Use Committee of Anhui Medical University in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH publication No. 85\u201323, revised 1985).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the contents of this manuscript and agreed to the manuscript be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"164"}}